JP2020525012A5 - - Google Patents

Download PDF

Info

Publication number
JP2020525012A5
JP2020525012A5 JP2019571258A JP2019571258A JP2020525012A5 JP 2020525012 A5 JP2020525012 A5 JP 2020525012A5 JP 2019571258 A JP2019571258 A JP 2019571258A JP 2019571258 A JP2019571258 A JP 2019571258A JP 2020525012 A5 JP2020525012 A5 JP 2020525012A5
Authority
JP
Japan
Prior art keywords
ecolin
phage
genes
genome
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019571258A
Other languages
English (en)
Japanese (ja)
Other versions
JP7358245B2 (ja
JP2020525012A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/038840 external-priority patent/WO2018237198A1/en
Publication of JP2020525012A publication Critical patent/JP2020525012A/ja
Publication of JP2020525012A5 publication Critical patent/JP2020525012A5/ja
Priority to JP2023093143A priority Critical patent/JP7639056B2/ja
Application granted granted Critical
Publication of JP7358245B2 publication Critical patent/JP7358245B2/ja
Priority to JP2025025000A priority patent/JP2025087727A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019571258A 2017-06-21 2018-06-21 障害の処置のための細菌 Active JP7358245B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2023093143A JP7639056B2 (ja) 2017-06-21 2023-06-06 障害の処置のための細菌
JP2025025000A JP2025087727A (ja) 2017-06-21 2025-02-19 障害の処置のための細菌

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US201762523202P 2017-06-21 2017-06-21
US201762523225P 2017-06-21 2017-06-21
US62/523,225 2017-06-21
US62/523,202 2017-06-21
US201762552785P 2017-08-31 2017-08-31
US201762552829P 2017-08-31 2017-08-31
US62/552,829 2017-08-31
US62/552,785 2017-08-31
US201862614213P 2018-01-05 2018-01-05
US62/614,213 2018-01-05
US201862624299P 2018-01-31 2018-01-31
US62/624,299 2018-01-31
PCT/US2018/038840 WO2018237198A1 (en) 2017-06-21 2018-06-21 Bacteria for the treatment of disorders

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023093143A Division JP7639056B2 (ja) 2017-06-21 2023-06-06 障害の処置のための細菌

Publications (3)

Publication Number Publication Date
JP2020525012A JP2020525012A (ja) 2020-08-27
JP2020525012A5 true JP2020525012A5 (enExample) 2021-07-26
JP7358245B2 JP7358245B2 (ja) 2023-10-10

Family

ID=62909623

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019571258A Active JP7358245B2 (ja) 2017-06-21 2018-06-21 障害の処置のための細菌
JP2023093143A Active JP7639056B2 (ja) 2017-06-21 2023-06-06 障害の処置のための細菌
JP2025025000A Pending JP2025087727A (ja) 2017-06-21 2025-02-19 障害の処置のための細菌

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2023093143A Active JP7639056B2 (ja) 2017-06-21 2023-06-06 障害の処置のための細菌
JP2025025000A Pending JP2025087727A (ja) 2017-06-21 2025-02-19 障害の処置のための細菌

Country Status (8)

Country Link
US (2) US11879123B2 (enExample)
EP (1) EP3642221A1 (enExample)
JP (3) JP7358245B2 (enExample)
CN (1) CN111655841A (enExample)
AU (2) AU2018290278B2 (enExample)
CA (1) CA3066085A1 (enExample)
IL (1) IL271085B2 (enExample)
WO (1) WO2018237198A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10610546B2 (en) 2015-05-13 2020-04-07 Synlogic Operating Company Inc. Bacteria engineered to reduce hyperphenylalaninemia
EP3682008A4 (en) 2017-09-14 2020-12-09 University of Massachusetts GENETICALLY MODIFIED MICRO-ORGANISMS AND THEIR METHODS OF USE
CN108048342B (zh) * 2017-10-26 2021-06-04 中国农业大学 一种耐压益生菌及其食品和制备方法
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
KR20220003030A (ko) 2019-04-29 2022-01-07 신로직 오퍼레이팅 컴퍼니, 인코포레이티드 살아 있는 세포 계수 기술에 의한 유전적으로 조작된 미생물의 계수
EP3962506A4 (en) * 2019-05-03 2022-07-13 University Of Massachusetts GENETICALLY MODIFIED MICROORGANISMS AND METHODS OF USE
CN114008070A (zh) * 2019-06-21 2022-02-01 因思科瑞普特公司 导致大肠杆菌赖氨酸产量增加的全基因组合理设计的突变
CN110592057B (zh) * 2019-09-27 2022-01-28 昆明理工大学 嵌合裂解酶ILTphg和编码此酶的多核苷酸
WO2021127648A1 (en) * 2019-12-19 2021-06-24 Auburn University Microbial ester production
US20230092431A1 (en) * 2020-01-14 2023-03-23 Synlogic Operating Company, Inc. Bacteria engineered to treat disorders in which oxalate is detrimental
CN111235169A (zh) * 2020-02-03 2020-06-05 昆明理工大学 一种GTP环化水解酶I基因folE及应用
WO2021173808A1 (en) * 2020-02-25 2021-09-02 Synlogic Operating Company, Inc. Recombinant bacteria engineered to treat diseases associated with uric acid and methods of use thereof
BR112022018571A2 (pt) 2020-03-20 2022-11-01 Synlogic Operating Co Inc Microrganismos manipulados para reduzir a hiperfenilalaninemia
US20220031771A1 (en) * 2020-07-31 2022-02-03 Iowa State University Research Foundation, Inc. Microencapsulated and chromosome integrated compositions for l-dopa microbiome therapy
CN111876400B (zh) * 2020-08-06 2022-05-24 昆明理工大学 一种常温裂解酶Sly和编码此酶的多核苷酸
AU2021393455A1 (en) 2020-12-02 2023-06-29 Synlogic Operating Company, Inc. Engineered microorganisms
CN116847860A (zh) * 2020-12-31 2023-10-03 同生运营公司 经工程化以减轻高苯丙氨酸血症的微生物
CN112662607A (zh) * 2021-01-07 2021-04-16 上海陶宇晟生物技术有限责任公司 具备表面展示苯丙氨酸解氨酶的工程益生菌
WO2022204406A1 (en) * 2021-03-24 2022-09-29 Synlogic Operating Company, Inc. Bacteria engineered to treat disorders in which oxalate is detrimental
CN113789276B (zh) * 2021-09-15 2023-05-12 千宠堂(福建)生物科技有限公司 一株产β-烟酰胺单核苷酸的植物乳杆菌及其应用
WO2023044479A1 (en) 2021-09-17 2023-03-23 Synlogic Operating Company, Inc. Methods for reducing hyperphenylalaninemia
CN116555063B (zh) * 2022-01-27 2025-08-08 中国海洋大学 动物双歧杆菌f1-7在降解苯丙氨酸中的应用
CN116179452A (zh) * 2022-07-11 2023-05-30 山东第一医科大学(山东省医学科学院) 一种用于治疗精氨酸酶缺乏症的工程益生菌及其构建方法和应用
JP2025534764A (ja) 2022-10-17 2025-10-17 シンロジック オペレーティング カンパニー インコーポレイテッド 高フェニルアラニン血症を軽減するためのフェニルアラニンアンモニアリアーゼ、フェニルアラニントランスポーターおよびl-アミノ酸デアミナーゼを発現する組み換え細菌

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
GB9107305D0 (en) 1991-04-08 1991-05-22 Unilever Plc Probiotic
CN1154845A (zh) 1996-09-09 1997-07-23 首都医学院附属北京红十字朝阳医院 能表达活性苯丙氨酸脱氨酶的基因工程菌口服制剂
US5989463A (en) 1997-09-24 1999-11-23 Alkermes Controlled Therapeutics, Inc. Methods for fabricating polymer-based controlled release devices
US6203797B1 (en) 1998-01-06 2001-03-20 Stephen C. Perry Dietary supplement and method for use as a probiotic, for alleviating the symptons associated with irritable bowel syndrome
EP1034787A1 (en) 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus strains preventing diarrhea caused by pathogenic bacteria
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
US7731976B2 (en) 2003-08-29 2010-06-08 Cobb And Company, Llp Treatment of irritable bowel syndrome using probiotic composition
JP4452914B2 (ja) 2003-09-08 2010-04-21 味の素株式会社 新規トランスポータタンパク質
CN101068919B (zh) * 2004-11-30 2011-08-10 Aeras全球Tb疫苗基金会 适用于产生和制备重组双链rna核壳的细菌包装菌株及其用途
TW200819540A (en) 2006-07-11 2008-05-01 Genelux Corp Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders
US9084434B2 (en) 2006-09-27 2015-07-21 Little Calumet Holdings Llc Probiotic oral dosage forms
US20100297249A1 (en) 2007-07-05 2010-11-25 North-West University Enhancement of the efficacy of therapeutic proteins
CN101586111B (zh) 2008-05-22 2012-03-07 北京三元基因工程有限公司 一种活性乳酸乳球菌制品的制备方法
EP2344626B1 (en) 2008-09-29 2017-03-29 Intrexon Actobiotics NV Reduced colonization of microbes at the mucosa
WO2011080505A2 (en) * 2009-12-28 2011-07-07 Bigdna Ltd Method of growing phage for commercial use
WO2011106874A1 (en) 2010-03-02 2011-09-09 Functional Technologies Corp. Functional enhancement of microorganisms to minimize production of acrylamide
US8129170B1 (en) 2010-12-06 2012-03-06 E.I. Du Pont De Nemours And Company Recombinant bacteria having the ability to metabolize sucrose
US9409950B2 (en) 2010-12-23 2016-08-09 Biogen Ma Inc. Linker peptides and polypeptides comprising same
US9017961B2 (en) 2012-03-05 2015-04-28 E.I. Du Pont De Nemours And Company Recombinant bacteria comprising novel sucrose transporters
CN104487581B (zh) 2012-06-22 2021-05-28 菲特吉恩公司 用于苯乙烯合成的酶和方法
CA2880620A1 (en) 2012-07-27 2014-01-30 University Of North Texas Genetically modified probiotic for the treatment of phenylketonuria (pku) disease
US20150246085A1 (en) 2012-11-01 2015-09-03 The Sydney Children's Hospital Network (Randwick & Westmead) Genetically-Modified Probiotic for Treatment of Phenylketonuria
WO2014138324A1 (en) 2013-03-07 2014-09-12 The General Hospital Corporation Compositions and methods for bacterial delivery of polypeptides
BR112017011923A2 (pt) 2014-12-05 2018-02-27 Synlogic Inc bactéria modificada para tratar doenças associadas com hiperamonemia
US10610546B2 (en) 2015-05-13 2020-04-07 Synlogic Operating Company Inc. Bacteria engineered to reduce hyperphenylalaninemia
JP7095993B2 (ja) 2015-03-02 2022-07-05 シンロジック オペレーティング カンパニー インコーポレイテッド 消化管炎症低下および/または消化管粘膜バリア強化の利益を享受する疾患処置のために操作された細菌
EP3294757B1 (en) 2015-05-13 2023-12-27 Synlogic Operating Company, Inc. Bacteria engineered to treat a disease or disorder
EP3307870B1 (en) 2015-06-10 2023-08-02 Synlogic Operating Company, Inc. Bacteria engineered to treat disorders involving the catabolism of a branched chain amino acid
WO2016210373A2 (en) 2015-06-24 2016-12-29 Synlogic, Inc. Recombinant bacteria engineered for biosafety, pharmaceutical compositions, and methods of use thereof
EP3377518B1 (en) 2015-11-16 2022-04-13 Synlogic Operating Company, Inc. Bacteria engineered to reduce hyperphenylalaninemia
US11723932B2 (en) 2016-01-11 2023-08-15 Synlogic Operating Company, Inc. Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells

Similar Documents

Publication Publication Date Title
JP7639056B2 (ja) 障害の処置のための細菌
JP2020525012A5 (enExample)
JP7592777B2 (ja) 高フェニルアラニン血症を低減させるように操作された細菌
JP7494345B2 (ja) 高フェニルアラニン血症を低減させるように操作された細菌
AU2016226234B2 (en) Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
US10273489B2 (en) Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
JP6817966B2 (ja) 高アンモニア血症に関連する疾患を治療するために操作された細菌
WO2016210373A2 (en) Recombinant bacteria engineered for biosafety, pharmaceutical compositions, and methods of use thereof
JP2018535678A5 (enExample)
CN115335066A (zh) 经工程化以治疗其中草酸盐有害的病症的细菌
US12011466B2 (en) Modified Escherichia coli strain Nissle and treatment of gastrointestinal disorder
CN119677529A (zh) 用于治疗关节炎疾病的犬尿氨酸氨基转移酶及其产物